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The molecular size of vasopressin receptors in the intact membrane-bound state was determined by radia- 
tion inactivation (target size analysis). For the V, receptor in rat liver a molecular size of (76f8) kDa was 
determined. For the V, receptor in rat kidney and bovine kidney molecular sizes of (95f4) and (108f 11) 
kDa were found. Statistical analysis gave evidence for size differences between rat liver and rat kidney recep-- 
tors or differences between rat liver and bovine kidney receptors, but not between kidney receptors from 
different species. The results suggest hat V, and V, receptors can be distinguished by functional properties 
as well as by their size. 
Vosopressin receptor Radiation inactivation Target size Plasma membrane 
1. INTRODUCTION 
Among the variety of physiological effects 
shown by the neurohypophyseal peptide hormone 
vasopressin, its antidiuretic action in the mam- 
malian kidney and its glycogenolytic activity in the 
liver have been extensively studied. Specific recep- 
tors for vasopressin have been identified in these 
target tissues, and biochemical analysis revealed 
different mechanisms of signal transfer [ 11. On the 
one hand, it is well known that the interaction of 
vasopressin with its receptor in the mammalian 
kidney activates the enzyme adenylate cyclase. On 
the other hand, there is recent evidence that the 
binding of vasopressin to its receptor in the rat 
liver induces the mobilization of intracellular Ca2’ 
with myo-inositol 1,4,5_triphosphate as second 
messenger [2]. Studies with structural analogs of 
the natural hormone have clearly shown different 
recognition patterns of vasopressin receptors in 
kidney and liver [1,3]. Therefore, mammalian 
vasopressin receptors from liver and kidney are 
now generally classified as Vi and V2 receptors [4]. 
* To whom correspondence should be addressed 
To examine whether the functional difference 
between the two types of vasopressin receptors 
(vasopressin isoreceptors [ 11) reflects a difference 
in molecular size, we determined this structural 
parameter of the Vr and VZ receptors in the 
membrane-bound state by radiation inactivation 
(target size analysis). This technique gives the func- 
tional size of a protein complex, rather than the 
molecular masses of individual polypeptides [5]. 
Knowledge of the functional molecular size of 
vasopressin receptors would also be valuable for 
the interpretation of affinity labeling studies. 
2. EXPERIMENTAL 
2.1. Plasma membrane preparations 
Plasma membranes from bovine kidney medulla 
and rat liver were prepared as described previously 
[3,6]. For the preparation of plasma membranes 
from rat kidney medulla the following procedure 
was applied: tissue derived from the medulla of rat 
kidneys was suspended in 0.9% NaCl, 1 mM 
EDTA (pH 7.4) and passed through a stainless 
steel tissue press. Particulate material was collected 
by centrifugation at 2000 x gm, for 5 min and 
resuspended in 0.25 M sucrose, 1 mM EDTA and 
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5 mM Hepps (pH 7.8) at a ratio of 5 ml medium 
per g medullary tissue. It was subsequently 
homogenized with a dounce homogenizer perform- 
ing 10 strokes with the loose pestle and 3 strokes 
with the tight one. The suspension was filtered 
through 3 layers of gauze and subsequently cen- 
trifuged at 600 x g,,,, for 10 min. The supernatant 
was recentrifuged at 50000 x g,, for 20 min, 
yielding a hard brown pellet and a fluffy layer. The 
latter was separated and further fractionated by 
Percoll density gradient centrifugation following 
the same protocol as described for the bovine 
kidney preparation [6]. By this method partially 
purified platsma membranes from rat kidney 
medulla were obtained containing 0.8 pmol 
specific vasopressin binding sites per mg protein. 
Before irradiation, the membranes. were washed 
free from sucrose by repeated pelleting and 
resuspension in 20 mM Hepps (pH 8.3). The final 
suspension was fractionated into polypropylene 
cups (300-500 ~1) and kept at - 80°C. 
2.2. Irradiation procedures 
10 MeV electrons were generated by a linear ac- 
celerator (CSF Thompson, Paris) at dose rates of 
2-3 Mrad/min. Samples were kept at - 85°C dur- 
ing irradiation using the sample holder described in 
[7], which was cooled by a stream of liquid 
nitrogen. To determine doses of radiation, 
radiochromic dye films (Far-West Technology, 
Goleta, CA) were inserted into separate positions 
of the sample holder. The radiation dose was 
estimated as described [7] and plotted against the 
position in the sample holder yielding a calibration 
curve. 
2.3. Assays 
The inactivation of vasopressin receptors was 
determined by measuring the decay of specific 
binding capacity for [3H][Arg*]vasopressin ([‘HI- 
AVP). The radioligand was either prepared with a 
specific radioactivity of 6.6 Ci/mmol [6] or ob- 
tained from New England Nuclear (47 Ci/mmol). 
All binding assays were performed in triplicate, 
using the filtration method as described [3]. Recep- 
tor density was. determined as the specific binding 
at a total concentration of lo-’ M [4H]AVP after 
30 min incubation at 30°C. This concentration 
leads to more than 90% saturation of receptor 
sites. As protein standards for the radiation 
384 
inactivation horse liver alcohol dehydrogenase 
(Boehringer, Mannheim, FRG) and the endoge- 
nous alkaline phosphatase of rat liver plasma 
membranes were used. Enzyme activity was deter- 
mined by photometric assays [8,9]. 
2.4. Data presentation and calculations 
For each irradiated sample the logarithm of bin- 
ding capacity or enzyme activity with standard 
deviation (SD) was calculated and the correspon- 
ding radiation dose was obtained from the calibra- 
tion curve. In all experiments a linear relationship 
was found as analysed by a weighted linear least 
squares regression. Doses yielding either 37% 
residual binding capacity or enzyme activity (D37) 
were calculated from the equations describing the 
regression lines. From the average 037 f SD de- 
rived from several separate experiments, the 
molecular size (in Da) of the corresponding recep- 
tor or standard enzyme was calculated using the 
empirically established equation [lo] 
molecular size = f x 6m4z37105 , 
where 037 is in Mrad and f = 2.1 is a temperature 
correction factor derived from [l 11. For the 
statistical analysis of target size differences, Stu- 
dent’s t-test was applied. 
3. RESULTS AND DISCUSSION 
The binding of ligands to membrane-bound 
receptors is characterized by two parameters: the 
maximal capacity reflecting the density of specific 
binding sites in the membrane and the binding af- 
finity, which is usually expressed as the dissocia- 
tion constant Ku. In accordance with the concept 
that one single hit with high energy electrons inac- 
tivates one target molecule 151, it has been shown 
for several membrane-bound receptors that ir- 
radiation with high energy electrons reduces the 
number of binding sites but not the binding affini- 
ty [12-141. To ensure that this assumption is also 
valid for vasopressin receptors the saturation 
isotherms of specific [3H]AVP-binding to ir- 
radiated and nonirradiated rat liver membranes 
were analysed. Fig.1 and table 1 demonstrate that 
the high energy radiation used in this study reduces 
the number of vasopressin receptor sites without 
influencing the binding affinity. 
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Fig.1. Scatchard analysis of saturation isotherms of 
specific t3H]AVP-binding torat liver plasma membranes 
before (0) and after irradiation (0, 2.8 Mrad; A, 
6.3 Mrad). 
For the plasma membranes isolated from bovine 
kidney, rat kidney and rat liver, linear inactivation 
plots of the specific binding sites were obtained 
(fig.2), indicating the presence of homogenous 
species of vasopressin receptors. Our finding con- 
firms the results of binding studies, which 
demonstrated non-cooperative binding of vaso- 
pressin to homogenous sites in those membranes 
PI. 
The functional molecular sizes of vasopressin 
isoreceptors in the membrane-bound state and of 
the standard enzymes calculated from the average 
Table 1 
Dissociation constants KD for the specific binding of 
[‘H]AVP to irradiated and nonirradiated plasma 
membranes from rat liver 
Irradiation dose (Mrad) KD(M) 
0 (6.9 f 1.2) x lo-i0 
2.8 (8.4 f 2.2) x lo-lo 
6.3 (7.6 f 0.9) x lo-” 
The KD valpes were calculated from the slopes of the 
regression lines presented in fig. 1. Error estimates are 
expressed as 95% confidence interval 
I Bovme kidney Ral kidney 
I 
Rat liver -I 
lrradiatlon dose (M rad I 
Fig.2. Inactivation plots of specific [3H]AVP-binding 
sites in plasma membranes from bovine kidney, rat 
kidney and rat liver. For graphic representation, the data 
from the two experiments which were closest to the 
average Ds7 value were combined. 
037 values are given in table 2. The good agree- 
ment of the known molecular mass of standard en- 
zymes with the functional molecular size deter- 
mined by target size analysis in our study, 
demonstrates the validity of the method. For the 
Vi receptor in rat liver (76 f 8) kDa was deter- 
mined, for the Vs receptor in rat kidney and bovine 
kidney (95 f 4) and (108 f 11) kDa, respectively, 
were found. For comparison, by hydrodynamic 
methods applied to solubilized hormone-receptor 
complexes, molecular masses of 83 and 80 kDa for 
Vi and VZ receptors from rat liver and rat kidney 
have been determined [151. 
Taking into account the experimental errors in 
both the target size analysis and the semi-empirical 
hydrodynamic method, the molecular size of 
vasopressin isoreceptors in the membrane-bound 
state is roughly the same as in detergent solution. 
However, in contrast to the results obtained by the 
hydrodynamic method [15], statistical analysis of 
our data reveals a significant size difference bet- 
ween the hepatic Vi and the renal Vz receptors of 
the rat @ < 0.01). The evidence for a size dif- 
ference between liver and kidney receptors is even 
greater if the values of vasopressin receptors from 
bovine kidney and the rat liver are compared (p < 
0.001). In contrast, no significance could be found 
for a size difference between the V2 receptors from 
rat and bovine kidney (p > 0.05). 
In conclusion, the results of the present study 
suggest hat the vasopressin receptors from mam- 
malian liver and kidney differ not only in their 
385 
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Table 2 
Molecular sizes of vasopressin receptors and standard enzymes 
Target n 037 Molecular size (kDa) 
(Mrad) 
Target size Reference 
Vasopressin receptor 
(rat liver) 9 17.8 f 1.9 76k 8 83= 
Vasopressin receptor 
(rat kidney) 3 14.2 f 0.6 95* 4 80a 
Vasopressin receptor 
(bovine kidney) 7 12.5 + 1.3 108 f 11 - 
Alcohol dehydrogenase 
(horse liver) 9 15.7 f 2.2 86 * 12 80b 
Alkaline phosphatase 10 18.7 + 2.3 72f 9 7oc 
(rat liver) 7sd 
a Based on the hydrodynamic characterization of solubilized hormone-receptor 
complexes [151 
b Molecular mass of the dimeric enzyme [la] 
’ Target size of the subunit when irradiated in the absence of K+-stimulation [lo] 
d Subunit size as determined by SDS-PAGE [9] 
The molecular sizes were calculated from the average D3-r values as described in section 
2. For comparison molecular size reference values are given 
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functional properties, but also in molecular size. 
Therefore, the VI and VZ receptors found in mam- 
malian tissues may represent products of different 
genes. 
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